Elena Toschi Selected Research

Dementia (Dementias)

3/2014

Sociodemographic, clinical and organisational factors associated with delayed hospital discharges: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Toschi Research Topics

Disease

22	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 09/2016
8	Hypoglycemia (Reactive Hypoglycemia) 05/2024 - 01/2018
8	Neoplasms (Cancer) 09/2019 - 11/2002
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2004
6	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2011 - 03/2002
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 11/2002
4	Insulin Resistance 08/2007 - 06/2004
3	Hyperglycemia 01/2020 - 02/2002
2	COVID-19 11/2022 - 11/2021
2	Obesity 01/2021 - 04/2006
2	Overweight 01/2021 - 04/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2005
2	Disease Progression 05/2017 - 02/2009
2	Infections 01/2012 - 11/2002
2	Inflammation (Inflammations) 04/2006 - 03/2005
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Hypertriglyceridemia 01/2020
1	Diabetes Complications 07/2019
1	Body Weight (Weight, Body) 11/2018
1	Uterine Cervical Dysplasia 05/2017
1	Carcinoma (Carcinomatosis) 05/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Cholangiocarcinoma 01/2016
1	Hypertrophy 01/2016
1	Liver Failure 01/2016
1	Starvation 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Dementia (Dementias) 03/2014
1	Shoulder Fractures 03/2014
1	Breast Neoplasms (Breast Cancer) 09/2012
1	Adenocarcinoma 01/2011
1	Hypertension (High Blood Pressure) 04/2006

Drug/Important Bio-Agent (IBA)

21	Insulin (Novolin)FDA Link 03/2024 - 02/2002
19	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 04/2006
7	HIV Protease InhibitorsIBA 05/2017 - 03/2002
5	Blood Glucose (Blood Sugar)IBA 04/2024 - 04/2017
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2024 - 07/2019
3	SugarsIBA 07/2019 - 01/2015
3	Saquinavir (Invirase)FDA Link 05/2017 - 08/2003
3	Indinavir (Crixivan)FDA Link 01/2011 - 08/2003
3	CytokinesIBA 04/2006 - 11/2002
2	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2011
2	DiamondIBA 01/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 09/2012
2	tat Gene Products (tat Protein)IBA 01/2016 - 01/2011
2	Trans-Activators (Trans-Acting Factor)IBA 01/2016 - 04/2006
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2011 - 02/2009
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 04/2006 - 06/2004
2	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2006 - 06/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2005 - 06/2004
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2024
1	GoldIBA 04/2024
1	Oxygen (Dioxygen)IBA 11/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	NAD (NADH)IBA 01/2020
1	Glucagon (Glukagon)FDA Link 01/2018
1	TabletsIBA 01/2018
1	CarbohydratesIBA 01/2018
1	Ritonavir (Norvir)FDA Link 05/2017
1	Azacitidine (5 Azacytidine)FDA Link 01/2017
1	Histones (Histone)IBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	romidepsin (FK228)FDA Link 01/2017
1	Drug CombinationsIBA 01/2017
1	MethyltransferasesIBA 05/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2016
1	Histone Deacetylase InhibitorsIBA 05/2016
1	BilirubinIBA 01/2016
1	VaccinesIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	FructoseIBA 01/2015
1	fibroblast growth factor 21IBA 01/2015
1	apicidinIBA 09/2012
1	Cytotoxins (Cytolysins)IBA 09/2012
1	AntigensIBA 09/2012
1	HMGB1 Protein (HMG1)IBA 09/2012
1	Docetaxel (Taxotere)FDA Link 09/2012
1	IntegrinsIBA 01/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 02/2009
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2007
1	Insulin ReceptorIBA 08/2007
1	Dihydrotachysterol (AT 10)IBA 08/2007
1	Plasminogen InactivatorsIBA 04/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2006
1	InterleukinsIBA 04/2006

Therapy/Procedure

10	Glycemic Control 01/2023 - 06/2004
10	Therapeutics 01/2022 - 11/2002
4	Injections 01/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2017
1	Ligation 01/2016
1	Hepatectomy 01/2016
1	Critical Care (Surgical Intensive Care) 03/2014